Interestingly, CCL22 (C-C motif chemokine ligand 22), one of the three ceRNAs we found to jointly predict survival, is a crucial mediator of Treg migration towards brain tumors [48–50] and specifically expressed in GBM (not in low-grade tumors) [47]. This evidence concerns the gene CCL22 and glioblastoma.